Recent Media & Articles


Zacks Small Cap Research

August 14, 2024

INAB: AML & GBM Clinical Update

Read More

Kuick Research

August 10, 2024

Safety and Efficacy Profiles of Gamma Delta T Cell-Based Therapies

Read More

Forbes

August 7, 2024

Father Of CAR T-Cell Therapy Sees 2024 As A Breakthrough Year For Brain Cancer Treatment

Read More

Nature Cancer

July 26, 2024

γδ T cells as Critical Anti-Tumor Immune Effectors

Read More

Zacks Small Cap Research

June 17, 2024

INAB: Initiating Coverage – Enhancing the Insurgents of the Immune System

Read More

CGT Live

June 13, 2024

IN8bio’s Gamma-Delta T-cell Therapy INB-100 Helps Maintain Complete Remissions After HSCT in Patients With Hematologic Malignancies

Read More

Zacks Small Cap Research

April 22, 2024

INAB: Initiating Coverage – Enhancing the Insurgents of the Immune System

Read More

Pharmaceutical Technology

March 2, 2024

Development of Gamma-Delta T-Cell Therapies

Read More

Drug Target Review

February 28, 2024

Gamma delta T cells: a rising star in cancer therapy

Read More

Benzinga

January 22, 2024

IIN8bio’s Phase 1 Clinical Trial Of INB-100 Offers Hope To Leukemia Patients With Promising Data

Read More

Benzinga

November 27, 2024

Harnessing The Power Of Gamma-Delta T Cells In Cancer Therapy: IN8bio’s Innovative Approach

Read More

PharmaExec

November 20, 2023

New Ways to Battle Cancer: Q&A With William Ho, CEO of IN8bio

Read More

Benzinga

November 2, 2023

How IN8bio Is Working To Reach Its Goal Of “Cancer Zero” – Making Cancer A Thing of The Past

Read More

Stat News

October 6, 2023

Long underappreciated, gamma-delta T cells may be key to colon cancer defense, study says

Read More

Trends in Cancer

September 23, 2023

Wargaming cancer: a strategy for future precision oncology?

Read More

Kuick Research

May 5, 2022

Gamma Delta T Cell Cancer Therapy Market Trends Forecast 2028

Read More